| | Reviews Cardiovascular risk reduction by reversing endothelial dysfunction:ARBs, ACE inhibitors, or both? Expectations from The ONTARGET Trial Programme Luis Miguel Ruilope, Josep Redón, and Roland Schmieder Vasc Health Risk Manag. 2007 February; 3(1): 1–9. PMCID: PMC1994043 A review of pulmonary arterial hypertension: role of ambrisentan Robyn J Barst Vasc Health Risk Manag. 2007 February; 3(1): 11–22. PMCID: PMC1994051 Moexipril and left ventricular hypertrophy George S Chrysant and PK Nguyen Vasc Health Risk Manag. 2007 February; 3(1): 23–30. PMCID: PMC1994034 Carvedilol in the treatment of chronic heart failure: Lessons from The Carvedilol Or Metoprolol European Trial Britt Kveiborg, Atheline Major-Petersen, Buris Christiansen, and Christian Torp-Pedersen Vasc Health Risk Manag. 2007 February; 3(1): 31–37. PMCID: PMC1994038 What is the future of peer review? Why is there fraud in science? Is plagiarism out of control? Why do scientists do bad things? Is it all a case of:“All that is necessary for the triumph of evil is that good men do nothing?” Chris R Triggle and David J Triggle Vasc Health Risk Manag. 2007 February; 3(1): 39–53. PMCID: PMC1994041 Cardiometabolic aspects of polycystic ovarian syndrome Li Wei Cho, Harpal S Randeva, and Stephen L Atkin Vasc Health Risk Manag. 2007 February; 3(1): 55–63. PMCID: PMC1994046 Foot ulcers in the diabetic patient, prevention and treatment Stephanie C Wu, Vickie R Driver, James S Wrobel, and David G Armstrong Vasc Health Risk Manag. 2007 February; 3(1): 65–76. PMCID: PMC1994045 Trandolapril/verapamil combination in hypertensive diabetic patients José A García Donaire and Luis M Ruilope Vasc Health Risk Manag. 2007 February; 3(1): 77–82. PMCID: PMC1994049 Inhaled human insulin (Exubera®): clinical profile and patient considerations Anthony H Barnett and Sri Bellary Vasc Health Risk Manag. 2007 February; 3(1): 83–91. PMCID: PMC1994047 A review of picotamide in the reduction of cardiovascular events in diabetic patients Andrea Celestini and Francesco Violi Vasc Health Risk Manag. 2007 February; 3(1): 93–98. PMCID: PMC1994050 Effect of lipid-lowering and anti-hypertensive drugs on plasma homocysteine levels Jutta Dierkes, Claus Luley, and Sabine Westphal Vasc Health Risk Manag. 2007 February; 3(1): 99–108. PMCID: PMC1994037 Management of atrial fibrillation Puneet Kakar, Christopher J Boos, and Gregory YH Lip Vasc Health Risk Manag. 2007 February; 3(1): 109–116. PMCID: PMC1994040 Vascular wall proteoglycan synthesis and structure as a target for the prevention of atherosclerosis Peter J Little, Mandy L Ballinger, and Narin Osman Vasc Health Risk Manag. 2007 February; 3(1): 117–124. PMCID: PMC1994044 Role of the vasodilator peptide angiotensin-(1–7) in cardiovascular drug therapy Christoph Schindler, Peter Bramlage, Wilhelm Kirch, and Carlos M Ferrario Vasc Health Risk Manag. 2007 February; 3(1): 125–137. PMCID: PMC1994039 Overweight, physical activity and high blood pressure in children: a review of the literature Brian Torrance, K Ashlee McGuire, Richard Lewanczuk, and Jonathan McGavock Vasc Health Risk Manag. 2007 February; 3(1): 139–149. PMCID: PMC1994042 A review of sitaxsentan sodium in patients with pulmonary arterial hypertension Aaron B Waxman Vasc Health Risk Manag. 2007 February; 3(1): 151–157. PMCID: PMC1994033 Original Research Relationship between glycemic status and progression of carotid intima-media thickness during treatment with combined statin and extended-release niacin in ARBI-TER 2 Allen J Taylor, Daming Zhu, Lance E Sullenberger, Hyun J Lee, Jeannie K Lee, and Karen A Grace Vasc Health Risk Manag. 2007 February; 3(1): 159–164. PMCID: PMC1994036 Effect of candesartan cilexetil on diabetic and non-diabetic hypertensive patients: meta-analysis of five randomized double-blind clinical trials Ramzi EL Féghali, Sophie Nisse-Durgeat, and Roland Asmar Vasc Health Risk Manag. 2007 February; 3(1): 165–171. PMCID: PMC1994048 Blood pressure normalization in a large population of hypertensive patients treated with perindopril/indapamide combination: results of the OPTIMAX trial Jean-Jacques Mourad, Viet Nguyen, Marilucy Lopez-Sublet, and Bernard Waeber Vasc Health Risk Manag. 2007 February; 3(1): 173–180. PMCID: PMC1994035 |